Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 8,400 shares at $70.42 ($592K) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market sale of $592k ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.42 | 8,300 | $584K | 98.8% |
| 2 | $71.14 | 100 | $7K | 1.2% |
| Total | $70.43 avg | 8,400 | $592K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |